Kelly Ayotte to Tour New Salem Business Friday

Submitted on behalf of Gamma Medica, Inc.

U.S. Sen. Kelly Ayotte will tour Gamma Medica, located at 12 Manor Parkway, Unit 3, in Salem, on Friday, Nov. 8, at 9:15 a.m.

Jim Calandra, president and CEO of Gamma Medica, Inc., and the Gamma Medica team will welcome Senator Ayotte with a tour of the facility, a technology review and visit with employees. Specializing in advanced digital molecular imaging technology, Gamma Medica’s product, the LumaGEM® Molecular Breast Imaging (MBI) system enables the early detection of breast cancer.

Approximately 40 percent of women have dense breast tissue which makes presently available mammography screening unlikely to identify early-stage cancers. Gamma Medica provides a leading-edge technology designed to aid breast radiologists in diagnosing difficult cases, particularly in women with dense breast tissue.

Gamma Medica is comprised of 25 employees with excellent imaging technology experience and expertise in the areas of research and development, product design and engineering, manufacturing, regulatory, sales and marketing and clinical trials.

About Gamma Medica, Inc.

Gamma Medica, Inc. is dedicated to the development of advanced digital imaging technologies that address the growing importance of overcoming the critical shortcomings of mammography and other screening modalities in the early detection of breast cancer. The company designs, builds and services the LumaGEM®  MBI system, the first commercially available, FDA-cleared planar, dual head, fully solidstate digital imaging system utilizing cadmium zinc telluride (CZT) technology for molecular breast imaging.

www.gammamedica.com